0000891417 false Q2 --12-31 2023 3161 3161 0000891417 2023-01-01 2023-06-30 0000891417 2023-08-14 0000891417 2023-04-01 2023-06-30 0000891417 2022-04-01 2022-06-30 0000891417 2022-01-01 2022-06-30 0000891417 2023-06-30 0000891417 2022-12-31 0000891417 us-gaap:NonrelatedPartyMember 2023-06-30 0000891417 us-gaap:NonrelatedPartyMember 2022-12-31 0000891417 us-gaap:RelatedPartyMember 2023-06-30 0000891417 us-gaap:RelatedPartyMember 2022-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-03-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000891417 us-gaap:RetainedEarningsMember 2023-03-31 0000891417 2023-03-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000891417 us-gaap:RetainedEarningsMember 2022-03-31 0000891417 2022-03-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-12-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000891417 us-gaap:RetainedEarningsMember 2022-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-12-31 0000891417 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000891417 us-gaap:RetainedEarningsMember 2021-12-31 0000891417 2021-12-31 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-04-01 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-04-01 2022-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000891417 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-01-01 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-01-01 2023-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0000891417 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2023-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000891417 us-gaap:RetainedEarningsMember 2023-06-30 0000891417 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-06-30 0000891417 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000891417 us-gaap:RetainedEarningsMember 2022-06-30 0000891417 2022-06-30 0000891417 NMGX:AppliedNanotechIncMember 2022-05-30 2022-05-31 0000891417 us-gaap:ParentMember 2022-05-30 2022-05-31 0000891417 NMGX:AppliedNanotechIncMember 2022-05-31 0000891417 NMGX:AppliedNanotechIncMember NMGX:MayTwoThousandTwentyFourMember 2022-05-30 2022-05-31 0000891417 NMGX:AppliedNanotechIncMember NMGX:MayTwoThousandTwentySixMember 2022-05-30 2022-05-31 0000891417 NMGX:AppliedNanotechIncMember 2023-01-01 2023-06-30 0000891417 us-gaap:ConvertibleDebtMember 2022-01-07 0000891417 us-gaap:ConvertibleDebtMember 2022-01-01 2022-01-07 0000891417 us-gaap:ConvertibleDebtMember NMGX:TwoInvestorsMember 2022-01-26 0000891417 us-gaap:ConvertibleDebtMember NMGX:TwoInvestorsMember 2022-01-31 0000891417 us-gaap:ConvertibleDebtMember 2022-01-26 0000891417 us-gaap:ConvertibleDebtMember 2022-01-31 0000891417 us-gaap:ConvertibleDebtMember 2022-01-26 2022-01-26 0000891417 us-gaap:ConvertibleDebtMember 2022-01-30 2022-01-31 0000891417 NMGX:ConvertibleDebtOneMember 2022-07-27 0000891417 NMGX:ConvertibleDebtTwoMember 2022-07-27 0000891417 NMGX:ConvertibleDebtOneMember 2022-07-27 2022-07-27 0000891417 NMGX:ConvertibleDebtTwoMember 2022-07-27 2022-07-27 0000891417 us-gaap:ConvertibleDebtMember 2022-08-22 0000891417 us-gaap:ConvertibleDebtMember 2022-08-19 2022-08-22 0000891417 us-gaap:ConvertibleDebtMember 2022-10-26 0000891417 us-gaap:ConvertibleDebtMember 2022-10-24 2022-10-26 0000891417 NMGX:ConvertiblePromissoryNotesMember 2022-12-18 0000891417 us-gaap:ConvertibleDebtMember 2023-06-14 0000891417 NMGX:ConvertiblePromissoryNotesMember 2023-06-30 0000891417 NMGX:ConvertiblePromissoryNotesMember 2022-12-31 0000891417 2022-01-01 2022-12-31 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2015-02-10 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2015-02-09 2015-02-10 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2019-06-18 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2019-06-17 2019-06-18 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2022-05-02 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2022-05-01 2022-05-02 0000891417 NMGX:NanoMagicLLCMember NMGX:EquipmentNoteMember 2022-12-31 0000891417 NMGX:MichiganFacilityMember 2020-08-11 0000891417 NMGX:MichiganFacilityMember 2020-08-10 2020-08-11 0000891417 NMGX:MichiganFacilityMember 2023-06-30 0000891417 NMGX:RaymondLeasingCorporationMember 2020-09-24 0000891417 NMGX:RaymondLeasingCorporationMember 2020-09-23 2020-09-24 0000891417 NMGX:RaymondLeasingCorporationMember 2023-06-30 0000891417 NMGX:ProductionEquipmentMember 2020-12-31 0000891417 NMGX:ProductionEquipmentMember 2020-12-01 2020-12-31 0000891417 NMGX:ProductionEquipmentMember 2023-06-30 0000891417 NMGX:ScottAndJeanneRickertMember 2023-06-30 0000891417 NMGX:ScottAndJeanneRickertMember 2022-12-31 0000891417 NMGX:JeanneRickertMember 2023-06-30 0000891417 NMGX:JeanneRickertMember 2022-12-31 0000891417 NMGX:TomBermanMember srt:MaximumMember 2023-06-30 0000891417 NMGX:TomBermanMember 2023-06-30 0000891417 NMGX:TomBermanMember 2023-01-01 2023-06-30 0000891417 srt:ChiefFinancialOfficerMember srt:MaximumMember 2023-05-31 0000891417 NMGX:ChiefFinancialOfficerAndGeneralCounselMember srt:MaximumMember 2023-06-30 0000891417 NMGX:ChiefFinancialOfficerAndGeneralCounselMember 2023-01-01 2023-01-31 0000891417 NMGX:RonaldBermanMember srt:MaximumMember 2023-05-31 0000891417 NMGX:HimanMember srt:MaximumMember 2023-05-31 0000891417 NMGX:HimanMember 2023-04-01 2023-04-30 0000891417 NMGX:AppliedNanoTechMember 2022-05-31 0000891417 NMGX:TomBermanandRonBermanMember 2023-01-01 2023-06-30 0000891417 NMGX:MilesGatlandMember 2023-01-01 2023-06-30 0000891417 NMGX:RonaldJBermanMember 2023-04-01 2023-06-30 0000891417 NMGX:RonaldJBermanMember 2022-04-01 2022-06-30 0000891417 NMGX:RonaldJBermanMember 2023-01-01 2023-06-30 0000891417 NMGX:RonaldJBermanMember 2022-01-01 2022-06-30 0000891417 NMGX:TomJBermanMember 2023-04-01 2023-06-30 0000891417 NMGX:TomJBermanMember 2022-04-01 2022-06-30 0000891417 NMGX:TomJBermanMember 2023-01-01 2023-06-30 0000891417 NMGX:TomJBermanMember 2022-01-01 2022-06-30 0000891417 NMGX:ScotteERickertMember 2023-04-01 2023-06-30 0000891417 NMGX:ScotteERickertMember 2022-04-01 2022-06-30 0000891417 NMGX:ScotteERickertMember 2023-01-01 2023-06-30 0000891417 NMGX:ScotteERickertMember 2022-01-01 2022-06-30 0000891417 2023-02-01 2023-02-28 0000891417 2023-02-28 0000891417 2023-05-02 0000891417 us-gaap:RestrictedStockMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestedInMayMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestAtEndOfMayMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestingInDecemberThirtyOneTwoThousandTwentyThreeMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestAtEndOfEachMonthInDecemberThirtyOneTwoThousandTwentyFourMember 2023-05-29 2023-05-30 0000891417 us-gaap:RestrictedStockMember NMGX:VestingAtEndOfDecemberThirtyOneTwoThousandTwentyFourMember 2023-05-29 2023-05-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-04-01 2023-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2023-01-01 2023-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2022-04-01 2022-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2022-06-30 0000891417 NMGX:CommonStockAndDerivativeEquitySecuritiesMember 2022-01-01 2022-06-30 0000891417 us-gaap:WarrantMember 2023-06-30 0000891417 us-gaap:WarrantMember 2023-01-01 2023-06-30 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2021-03-02 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2021-04-08 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2021-04-05 2021-04-08 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2021-06-21 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2021-06-20 2021-06-21 0000891417 2022-02-01 2022-02-28 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2023-04-12 2023-04-12 0000891417 NMGX:TwoThousandTwentyOneEquityIncentivePlanMember 2023-05-29 2023-05-30 0000891417 NMGX:TomJBermanMember 2023-04-12 2023-04-12 0000891417 NMGX:OfficersMember 2023-05-30 2023-05-30 0000891417 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0000891417 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0000891417 us-gaap:WarrantMember 2023-01-01 2023-06-30 0000891417 us-gaap:WarrantMember 2022-01-01 2022-12-31 0000891417 2023-06-16 0000891417 us-gaap:SubsequentEventMember 2023-07-24 0000891417 us-gaap:SubsequentEventMember 2023-07-23 2023-07-24 0000891417 us-gaap:SubsequentEventMember 2023-08-02 2023-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure NMGX:Segment utr:sqft

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

Quarterly report under Section 13 or 15(d) of the Securities Exchange Act of 1934

 

For the quarterly period ended June 30, 2023

 

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

COMMISSION FILE NO. 1-11602

 

NANO MAGIC INC.

(Exact name of registrant as specified in its charter)

 

Delaware   47-1598792
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

31601 Research Park Drive, Madison Heights, MI 48071

(Address of principal executive office, including Zip Code)

 

Registrant’s telephone number, including area code: (844) 273-6462

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

Title of each class   Trading Symbol   Name of Each Exchange on Which Registered
Common Stock, $0.0001 par value   NMGX   OTC Markets

 

Securities registered pursuant to Section 12(g) of the Exchange Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☐ Yes ☒ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “accelerated filer”, “large accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
   
Non-accelerated filer ☐ (Do not check if a smaller reporting company) Smaller reporting company

 

Emerging growth company

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No.

 

As of August 14, 2023, the registrant had 11,429,666 shares of Common Stock issued and outstanding.

 

 

 

 
 

 

Nano Magic Inc.

 

INDEX

 

    Page
Part I. Financial Information    
     
Item 1. Financial Statements (Unaudited)   F-1
     
Condensed Consolidated Statements of Operations—Three and Six Months Ended June 30, 2023 and 2022   F-1
     
Condensed Consolidated Balance Sheets—June 30, 2023 and December 31, 2022   F-2
     
Condensed Consolidated Statements of Changes in Stockholders’ Equity for the Three Months Ended June 30, 2023 and 2022   F-3
     
Consolidated Statements of Changes in Stockholders’ Equity for the Six Months Ended June 30, 2023 and 2022 (unaudited)   F-4
     
Condensed Consolidated Statements of Cash Flows—Six Months Ended June 30, 2023 and 2022   F-5
     
Notes to Unaudited Condensed Consolidated Financial Statements   F-6
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   4
     
Item 3. Quantitative and Qualitative Disclosures about Market Risk   7
     
Item 4. Controls and Procedures   8
     
Part II. Other Information    
     
Item 1. Legal Proceedings   8
     
Item 1A. Risk Factors   8
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   8
     
Item 3. Defaults Upon Senior Securities   9
     
Item 4. Mine Safety Disclosures   9
     
Item 5. Other Information   9
     
Item 6. Exhibits   9
     
Signatures   10

 

2
 

 

FORWARD-LOOKING STATEMENTS

 

This Form 10-Q contains certain forward-looking statements that we believe are within the meaning of the federal securities laws. For this purpose, any statements that are not statements of historical fact may be deemed to be forward-looking statements, including the statements under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding our strategy, future operations, future expectations or future estimates, financial position and objectives of management. Those statements in this Form 10-Q containing the words “believes,” “anticipates,” “plans,” “expects” and similar expressions constitute forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on our current expectations and are subject to a number of risks, uncertainties and assumptions relating to our operations, results of operations, competitive factors, shifts in market demand and other risks and uncertainties.

 

Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate and actual results may differ from those indicated by the forward-looking statements included in this Form 10-Q. In light of the significant uncertainties inherent in the forward-looking statements included in this Form 10-Q, you should not consider the inclusion of such information as a representation by us or anyone else that we will achieve such results. Moreover, we assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking statements.

 

3
 

 

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
NET REVENUES   $709,293   $493,782   $1,406,322   $1,012,925 
                     
COST OF SALES    507,155    458,330    1,129,434    990,894 
                     
GROSS PROFIT    202,138    35,452    276,888    22,031 
                     
OTHER OPERATING INCOME    11,420    -    11,420    - 
                     
OPERATING EXPENSES:                     
Selling and marketing expenses    54,018    96,301    113,442    175,830 
Salaries, wages and related benefits    189,986    316,752    468,562    712,718 
Stock compensation expense    260,249    39,366    290,393    106,621 
Research and development    6,371    3,211    12,275    10,700 
Professional fees    112,762    188,794    302,221    442,773 
General and administrative expenses    258,508    211,463    447,514    463,261 
                     
Total Operating Expense    881,894    855,887    1,634,407    1,911,903 
                     
LOSS FROM OPERATIONS    (668,336)   (820,435)   (1,346,099)   (1,889,872)
                     
OTHER INCOME (EXPENSE)                     
Income (loss) from investment in subsidiary    8,782    (3,161)   40,938    (3,161)
Interest expense    (7,575)   (8,337)   (21,943)   (15,635)
Other income    16,264    3,886    23,202    2,625 
Total Other Income (Expense)    17,471    (7,612)   42,197    (16,171)
                     
LOSS FROM CONTINUING OPERATIONS    (650,865)   (828,047)   (1,303,902)   (1,906,043)
                     
INCOME (LOSS) FROM DISCONTINUED OPERATIONS                     
Income (loss) from discontinued operations    -    (13,045)   -    1,300 
Gain on sale of discontinued operations    -    1,148,225    -    1,148,225 
                     
NET INCOME FROM DISCONTINUED OPERATIONS    -    1,135,180    -    1,149,525 
                     
NET (LOSS) INCOME   $(650,865)  $307,133   $(1,303,902)  $(756,518)
                     
NET (LOSS) INCOME PER SHARE - BASIC:                     
Continuing operations   $(0.06)  $(0.08)  $(0.12)  $(0.19)
Discontinued operations   $-   $0.11   $-   $0.11 
NET (LOSS) INCOME PER SHARE - BASIC:   $(0.06)  $0.03   $(0.12)  $(0.08)
                     
NET (LOSS) INCOME PER SHARE - DILUTED:                     
Continuing operations   $(0.06)  $(0.08)  $(0.12)  $(0.19)
Discontinued operations   $-   $0.11   $-   $0.11 
NET (LOSS) INCOME PER SHARE - DILUTED:   $(0.06)  $0.03   $(0.12)  $(0.08)
                     
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:                     
Basic    10,963,268    10,084,334    10,907,579    10,082,511 
Diluted    10,963,268    10,084,334    10,907,579    10,082,511 

 

See accompanying notes to condensed consolidated financial statements.

 

F-1
 

 

NANO MAGIC INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

 

   June 30   December 31 
   2023   2022 
ASSETS          
           
CURRENT ASSETS:           
Cash   $19,813   $259,223 
Accounts receivable, net   353,750    348,565 
Inventory, net    1,049,562    1,120,073 
Prepaid expenses    23,203    132,997 
Current portion of note receivable   45,000    40,000 
Total Current Assets   1,491,328    1,900,858 
Operating lease right-of-use assets    943,100    1,037,749 
Property, plant and equipment, net    472,373    525,809 
Note receivable, non-current    326,175    375,983 
Non-marketable equity investment in subsidiary    291,085    250,146 
Total Assets   $3,524,061   $4,090,545 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
CURRENT LIABILITIES:           
Accounts payable   $690,066   $762,524 
Accounts payable - related parties   100,617    87,119 
Accrued expenses and other current liabilities   327,761    276,132 
Current portion of notes payable    25,000    26,629 
Current portion of finance leases   26,248    39,005 
Advances from related parties   42,887    42,887 
Current portion of operating lease liabilities   153,488    142,173 
Total Current Liabilities   1,366,067    1,376,469 
Notes payable and debt discount, net of current portion    394,667    350,000 
Finance leases, net of current portion    12,396    24,194 
Operating lease liabilities, net of current portion    630,646    722,420 
Total Liabilities     2,403,776    2,473,083 
           
Commitments and Contingencies (See Note 11)   -    - 
           
STOCKHOLDERS’ EQUITY:           
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding   -    - 
Common stock: $0.0001 par value, 30,000,000 shares authorized; 11,180,953 and 10,722,431 issued and outstanding at June 30, 2023 and December 31, 2022, respectively   1,117    1,072 
Additional paid-in capital   14,569,823    13,763,143 
Accumulated deficit   (13,450,655)   (12,146,753)
Total Stockholders’ Equity   1,120,285    1,617,462 
Total Liabilities and Stockholders’ Equity  $3,524,061   $4,090,545 

 

See accompanying notes to consolidated financial statements.

 

F-2
 

 

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED JUNE 30, 2023 AND 2022

(unaudited)

 

   Shares   Amount   Capital   Deficit   Equity 
   Class A Common Stock   Additional
Paid-in
   Accumulated   Total
Stockholders’
 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance, March 31, 2023   10,850,037   $1,084   $13,954,274   $(12,799,790)  $1,155,568 
                          
Common stock issued for cash, net of issuance costs   253,994    25    346,039    -    346,064 
                          
Stock-based compensation   -    -    255,539    -    255,539 
                          
Stock issued for services   76,922    8    4,702    -    4,710 
                          
Warrants and options on private placement   -    -    9,269    -    9,269 
                          
Net loss   -    -    -    (650,865)   (650,865)
                          
Balance, June 30, 2023   11,180,953    1,117    14,569,823    (13,450,655)   1,120,285 
                          
Balance, March 31, 2022   10,077,681   $1,008   $12,702,228   $(11,108,815)  $1,594,421 
                          
Common stock issued for cash, net of issuance costs   283,334    28    495,806    -    495,834 
                          
Stock-based compensation   -    -    39,366    -    39,366 
                          
Warrants and options on private placement   -    -    14,165    -    14,165 
                          
Net Income   -    -    -    307,133    307,133 
                          
Balance, June 30, 2022   10,361,015    1,036    13,251,565    (10,801,682)   2,450,919 

 

See accompanying notes to condensed consolidated financial statements.

 

F-3
 

 

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE SIX MONTHS ENDED JUNE 30, 2023 AND 2022

(unaudited)

 

   Class A Common Stock   Additional
Paid-in
   Accumulated   Stockholders’ 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance, December 31, 2022   10,722,431   $1,072   $13,763,143   $(12,146,753)  $1,617,462 
                          
Common stock issued for cash, net of issuance costs   328,800    32    439,539    -    439,571 
                          
Stock-based compensation   -    -    285,683    -    285,683 
                          
Stock issued for services   52,800    5    65,995    -    66,000 
                          
Restricted stock issued for services   76,922    8    4,702    -    4,710 
                          
Warrants and options on private placement   -    -    10,761    -    10,761 
                          
Net loss   -    -    -    (1,303,902)   (1,303,902)
                          
Balance, June 30, 2023   11,180,953    1,117    14,569,823    (13,450,655)   1,120,285 
                          
Balance, December 31, 2021   9,702,680   $970   $11,960,011   $(10,045,164)  $1,915,817 
                          
Common stock issued for cash, net of issuance costs   658,335    66    1,152,020    -    1,152,086 
                          
Stock-based compensation   -    -    106,621    -    106,621 
                          
Warrants and options on private placement   -    -    32,913    -    32,913 
                          
Net loss   -    -    -    (756,518)   (756,518)
                          
Balance, June 30, 2022   10,361,015    1,036    13,251,565    (10,801,682)   2,450,919 

 

See accompanying notes to condensed consolidated financial statements.

 

F-4
 

 

NANO MAGIC INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   2023   2022 
   For the Six Months Ended 
   June 30, 
   2023   2022 
         
CASH FLOWS FROM OPERATING ACTIVITIES          
Net loss from continuing operations  $(1,303,902)  $(1,906,043)
Net income from discontinued operations   -    1,149,525 
Adjustments to reconcile net loss to net cash provided by operating activities:          
Change in inventory obsolescence reserve   (3,680)   2,331 
Depreciation and amortization expense   56,265    56,159 
Bad debt expense   47,997    30,629 
Stock-based compensation and stock issued for services   356,393    106,621 
Income from investment in subsidiary   (40,938)   - 
Change in operating assets and liabilities:          
Accounts receivable   (53,181)   23,121 
Inventory   74,190    52,166 
Prepaid expenses and contract assets   109,794    30,636 
Accounts payable   (47,650)   249,340 
Accounts payable - related party   13,498    (6,065)
Operating lease liabilities   14,190    29,575 
Accrued expenses   51,629    79,607 
Contract liabilities   -    159,688 
Total adjustments   578,507    813,808 
           
Net cash used by continuing operating activities   (725,395)   (1,092,235)
Net cash used by discontinued operating activities   -    (70,945)
           
NET CASH USED BY OPERATING ACTIVITIES   (725,395)   (1,163,180)
           
CASH FLOWS FROM CONTINUING INVESTING ACTIVITIES          
Proceeds from note receivable   20,000    - 
Purchases of property and equipment   (2,829)   (4,910)
           
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES   17,171    (4,910)
           
CASH FLOWS FROM CONTINUING FINANCING ACTIVITIES          
Proceeds from sale of common stock and warrants   445,000    1,184,999 
Proceeds from issuance of convertible debt and warrants   50,000    200,000 
Repayment of bank loans   (1,630)   (15,454)
Repayment of finance leases   (24,556)   (20,334)
Repayment of advances from related parties   -    (51,065)
Net cash provided by continuing financing activities   468,814    1,298,146 
Net cash provided by discontinued financing activities   -    20,000 
           
NET CASH PROVIDED BY FINANCING ACTIVITIES   468,814    1,318,146 
           
NET (DECREASE) INCREASE IN CASH   (239,410)   150,056 
           
CASH in continuing operations, beginning of period   259,223    197,932 
CASH in discontinued operations, beginning of period   -    44,542 
           
CASH, end of period  $19,813   $392,530 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION          
Cash paid during the period for interest  $21,943   $15,635 

 

See accompanying notes to condensed consolidated financial statements.

 

F-5
 

 

NANO MAGIC INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2023

(unaudited)

 

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

Organization

 

Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology. On March 2, 2021 we changed our name to Nano Magic Holdings Inc. On December 31, 2022, our wholly-owned subsidiary Nano Magic LLC was merged into the parent company and we changed our name to Nano Magic Inc.

 

Effective May 31, 2022, we sold a 70% interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). The contract research services performed by ANI for governmental and private customers was previously reported as our Contract research segment. As a result of this sale, the Company has deconsolidated ANI from its financial reporting, and we now report as only one segment. We retain a 30% interest in ANI that is now recorded as an equity investment.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. The balance sheet at December 31, 2022 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures of the Company as of December 31, 2022 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 11, 2023.

 

Going Concern

 

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had losses from continuing operations and net cash used by continuing operations of $1,303,902 and $725,395 for the six months ended June 30, 2023 and a loss from continuing operations of $1,906,043 and cash used by continuing operations $1,092,235 for the six months ended June 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited consolidated financial statements are issued. Management cannot provide assurance that the Company will ultimately achieve profitable operations, become cash flow positive or raise additional capital. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. They do not include any adjustments related to the recoverability and/or classification of the recorded asset amounts and/or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Reclassifications

 

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.

 

NOTE 2 – DISCONTINUED OPERATIONS

 

Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of its officers and long-term employees in exchange for a promissory note in the face amount of $450,000. The note bears interest at 7% and has semi-annual payments of principal initially in the amount of $20,000, increasing to $25,000 in May 2024 and to $30,000 in May 2026, with a final balloon payment of $80,000 due on December 31, 2029. The note is secured by a stock pledge, described below. In conjunction with the sale, we recognized a one-time gain of $1,148,225.

 

F-6
 

 

In connection with the sale, the capital structure of Applied Nanotech was changed to give us, as the holder of Class B common stock of Applied Nanotech, a 30% economic interest, certain information rights, special consent rights, and tag-along rights, as well as the obligation to sell our stock under certain circumstances if other stockholders are selling. The Class A stock acquired by the buyers was pledged to secure the promissory note given in payment of the purchase price.

 

The following includes the detail of major classes of assets and liabilities of discontinued operations summarized on the accompanying unaudited consolidated financial statements:

 

The following is the detail of major line items that constitute income (loss) from discontinued operations:

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Net Revenues  $-   $91,329   $-   $258,444 
Cost of Sales   -    76,947    -    211,029 
Gross Profit   -    14,382    -    47,415 
                     
Salaries, wages and related benefits   -    17,684    -    23,573 
General and administrative expenses   -    9,514    -    21,961 
Professional fees   -    -    -    - 
Interest and other expense   -    229    -    581 
Net income (loss) on discontinued operations  $-   $(13,045)  $-   $1,300 

 

 

NOTE 3 – INVENTORY

 

At June 30, 2023 and December 31, 2022, inventory consisted of the following:

 

    June 30, 2023     December 31, 2022  
Raw materials   $ 665,155     $ 695,774  
Work-in-progress     241,110       256,095  
Finished goods     324,495       353,082  
Inventory, gross     1,230,760       1,304,951  
Less: reserve for obsolescence     (181,198 )     (184,878 )
Inventory, net   $ 1,049,562     $ 1,120,073  

 

NOTE 4 – INVESTMENT IN SUBSIDIARY

 

The Company is accounting for its 30% ownership interest in ANI by the equity method of accounting under which the Company’s share of the net income (loss) of ANI is recognized as income (loss) in the Company’s statement of operations. Any dividends received from ANI as well as periodic losses for the Company’s 30% share will be treated as a reduction of the investment account. At June 30, 2023, the investment was $291,085, included in non-current assets. For the three- and six-month periods ended June 30, 2023, the Company recorded income from the investment in the subsidiary of $8,782 and $40,938 respectively. For the three and six-month periods ended June 30, 2022, the Company recorded a net loss from the investment in subsidiary of $3,161.

 

NOTE 5 – NOTES PAYABLE AND FINANCE LEASES

 

Notes Payable

 

On January 7, 2022, the Company sold to one investor a $100,000 convertible note due March 31, 2025. On January 26, 2022, and January 31, 2022, the Company sold two $50,000 convertible notes to two different investors. The two $50,000 notes are due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On July 27, 2022, the Company sold two convertible notes, one for $50,000 and one for $25,000, both due on March 31, 2025. On August 22, 2022, the Company sold a $25,000 convertible promissory note due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

F-7
 

 

On October 26, 2022, the Company sold to an investor a $25,000 convertible promissory note due October 31, 2023. Issued at face value, the note bears interest at 8% per annum, payable semi-annually in cash. The note is convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On December 18, 2022, the Company issued a convertible promissory note for $50,000 that is secured by certain payroll tax credits the Company is entitled to receive under the Employee Retention Tax Credit program. The note was issued at face value and bears interest at 8% per annum, payable at maturity which is eighteen months from date of issue. The note can be converted to common stock at any time at the option of the holders at a conversion price of $1.75 per share at which point accrued interest will be paid in cash.

 

On June 14, 2023, the Company issued a convertible, secured note and warrants to purchase 10,000 shares of the Company’s common stock for $50,000 with the same terms as the one issued on December 18, 2022. The warrants were recorded as a debt discount on the date of issuances for a total value of $5,333.

 

At June 30, 2023 and at December 31, 2022, we had outstanding convertible notes aggregating $419,667 and $375,000 in principal amount, net of unamortized debt discount of $5,333 and $0, respectively. The convertible promissory notes have not been included in diluted earnings per share as they would be anti-dilutive.

 

On February 10, 2015, Nano Magic entered into a $373,000 promissory note (the “Equipment Note”) with KeyBank, N.A. (the “Bank”). The unpaid principal balance of this Equipment Note was payable in 60 equal monthly instalments payments of principal and interest through June 10, 2020. The Equipment Note was secured by certain equipment, as defined in the Equipment Note, and bore interest computed at a rate of interest of 4.35% per annum based on a year of 360 days. On June 18, 2019, Nano Magic entered into an Amendment to the Equipment Note with the Bank. By the amendment, the maturity date of the note was extended until April 10, 2022, the interest rate was raised to 6.29% per year, and the monthly payments were reduced to $4,053 per month, including interest. On May 2, 2022, we amended the Equipment Note with Key Bank to extend the due date on the note until December 10, 2022. The interest rate remained the same at 6.29% per year and the monthly payments remained at $4,053 per month. At June 30, 2023, the principal amount due under the Equipment Note had been paid in full. At December 31, 2022, $1,629 was outstanding under the Equipment Note.

 

Finance Leases

 

On August 11, 2020, the company entered into a finance lease for furniture. We financed $60,684 over a period of 36 months with monthly payments of $1,972 during that time. As of June 30, 2023, the balance on the lease was $1,955 all of which is current.

 

On September 24, 2020, the company entered into a finance lease with Raymond Leasing Corporation for a forklift. Nano Magic LLC financed $14,250. The lease term is 36 months with monthly payments of $425. As of June 30, 2023, the balance on the lease was $1,266, all of which is current.

 

In December 2020, the company entered into a finance lease for production equipment. We financed $85,000 over a period of 48 months with monthly payments of $2,135 during that time. As of June 30, 2023, the balance on the lease was $35,422; the current and non-current portions were $23,026 and $12,396, respectively.

 

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At June 30, 2023 and at December 31, 2022, accounts payable – related parties totaled $100,617 and $87,119, respectively, and is presented separately in current liabilities. These balances consist of amounts owed to directors and officers as well as to the landlord controlled by two of the Company’s directors.

 

Other compensation paid to directors was:

 

   2023   2022   2023   2022 
   Three Months ended June 30,   Six Months ended June 30, 
   2023   2022   2023   2022 
Ronald J. Berman   $-    $30,000+  $-   $84,150+
Tom J. Berman   $

60,000

*  $60,300*  $

120,000

*  $115,600*
Scott E. Rickert   $ -    $ 15,000++  $ -    $30,000++

 

+ Legal and consulting fees.
* Indicates gross amount accrued as salary. In an effort to save cash, the company is satisfying the accrued salary through a combination of cash and stock in each period.
++ Repayment of advances previously made to the Company

 

F-8
 

 

At June 30, 2023 and at December 31, 2022, aggregate advances from Scott & Jeanne Rickert were $42,887. On both those dates, accrued payroll for the Rickerts was an aggregate of $16,000, which is included within accounts payable – related parties on the accompanying balance sheets.

 

We granted options to our President and CEO Tom Berman in lieu of salary: In April, an option to purchase up to 30,000 shares, fully vested for salary not paid from January to March, and, in May, a second option for up to 69,228 shares that vest at the rate of 7,692 shares monthly for salary not paid in April and subsequent months of 2023. Also in May, we granted our Chief Financial Officer an option for up to 100,000 shares in recognition of his services from 2019 through 2022. Both our CFO and our General Counsel were granted options in May for up to 60,000 shares, vesting 5,000 shares per month starting in January 2023 and each month thereafter. In May, 2023, we also granted director Ronald Berman an option to purchase up to 50,000 shares for services previously rendered and granted him an option for 45,000 shares that vest at the rate of 5,000 shares per month beginning in April and for each calendar month of 2023. All options have an exercise price of $0.65 per share and a four-year term.

 

One of the purchasers of the 70% interest in Applied Nanotech in May, 2022, was Richard Fink who was one of our named executive officers until that sale.

 

Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022. See the subsection on Sales of Stock under Issuances of Common Stock in Note 7.

 

In addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability company that is our landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a 5% economic interest in the landlord entity. Another director, Miles Gatland, owns a 12.5% interest in the Michigan landlord and he is a co-guarantor on the debt of that limited liability company. The lease for the Michigan facility gives us the right, during the first three years of the lease, to buy up to a 49% interest in the landlord for a price equal to 49% of the contributions received from other members. See Note 7, Stockholder’s Equity regarding the issuance of stock in partial satisfaction of unpaid rent. At June 30, 2023 and at December 31, 2022, rents accrued and unpaid totaled $57,111 and $57,119, respectively.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Description of Preferred and Common Stock

 

Preferred Stock

 

The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.

 

Common Stock

 

The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders.

 

Issuances of Common Stock

 

Common Stock Issued for Services

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept 52,800 shares of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. Those shares were issued in March, 2023.

 

F-9
 

 

In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024.

 

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect 4,273 shares vested in May for prior service, and another 4,273 shares vest at the end of May and each calendar month thereafter, with 4,277 shares vesting in December 2023. During 2024, 3,205 shares will vest at the end of each month, with 3,206 shares vesting at the end of December 2024.

 

Sales of Common Stock and Derivative Equity Securities

 

During the quarter ended June 30, 2023, the Company sold 253,994 shares of common stock for proceeds of $346,064 and warrants to purchase up to 196,813 shares of common stock for proceeds of $4,136. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. During the six-months ended June 30, 2023 the Company sold 328,800 shares of common stock for proceeds of $439,571 and warrants to purchase up to 271,439 shares of common stock for proceeds of $5,428. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. Also during the three-months ended June 30, 2023, the Company sold 10,000 warrants in connection with the issuance of a convertible note payable of $50,000 as disclosed in Note 5. In accordance with ASC 470, 11% of the value of the total convertible note payable was allocated to the warrants.

 

During the quarter ended June 30, 2022, the Company sold 283,334 shares of common stock for proceeds of $495,834 and warrants to purchase up to 283,310 shares of common stock for proceeds of $14,165. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $2.25. During the six-months ended June 30, 2022, the Company sold 658,335 shares of common stock for proceeds of $1,152,086 and warrants to purchase up to 658,275 shares of common stock for proceeds of $32,913. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $2.25.

 

Stock Options

 

Stock options to purchase common stock outstanding at June 30, 2023 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2022   2,760,991   $0.77    4.09   $777,723 
Exercised   -    -    -    - 
Issued   636,909    0.65    3.90    222,918 
Expired & forfeited   (21,580)   0.88    -    (5,382)
Outstanding June 30, 2023   3,376,320   $0.71    3.65   $995,259 
                     
Exercisable June 30, 2023   1,686,793   $0.67    2.92   $552,087 

 

 

    June 30, 2023     December 31, 2022  
Stock options     3,376,320       2,760,991  
Stock warrants     7,722,078       7,440,639  
Total     11,098,398       10,201,630  

 

F-10
 

 

Warrants

 

As of June 30, 2023, there were outstanding and exercisable warrants to purchase 7,722,078 shares of common stock. On May 26, 2022, the Board acted to extend the term of warrants that were issued in 2018, 2019, or the first quarter of 2020, adding an additional two years to the term of each of the 4,052,003 warrants issued in that period. The outstanding warrants have a weighted average exercise price of $1.72 per share and a weighted average remaining contractual term of 23.9 months. As of June 30, 2023, there was no intrinsic value for the warrants. No warrants have been included in diluted earnings per share as they would be anti-dilutive.

 

2021 Equity Incentive Plan

 

On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success. Initially, 85,000 shares were available for issuance under the Plan and that number of options were also granted to employees on March 2, 2021. On April 8, 2021 the number of shares under the Plan was increased by 2,500, and an additional 2,500 options were granted. On June 21, 2021 an additional 200,000 shares were made available for issuance under the Plan and options for 100,000 shares were granted, but subsequently forfeited. In February 2022, we granted 130,700 options with an exercise price of $0.80 and weighted average fair value on the grant date of $0.60.

 

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional 175,071 options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $0.65.

 

Other Options

 

On April 12, 2023, the Company issued an additional 30,000 options to Tom J. Berman, our President. On May 30, 2023, the Board granted 384,228 options to officers and to a consultant who is also a director.

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of June 30, 2023 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of June 30, 2023, the Company has not accrued any amount for litigation contingencies.

 

NOTE 9 – SUBSEQUENT EVENTS

 

On June 16, 2023, the Company issued a note at face value of $50,000 and sold that investor, for a price of $0.02 per warrant, warrants to purchase up to 10,000 shares of common stock at an exercise price of $1.75. In July 24, 2023, the Company sold a convertible note at its face amount of $50,000. On that same day, the Company sold 133,333 shares of common stock for proceeds of $100,000.

 

On July 19, 2023, the Board authorized the creation of an Advisory Committee. In August the Company agreed to issue to each of three individuals who will serve on that committee a total of 38,460 shares of restricted stock for their services during 2023.

 

F-11
 

 

ITEM 2: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying unaudited condensed consolidated financial statements.

 

OVERVIEW

 

Nano Magic is a leader in developing and bringing to market cutting-edge nanotechnology-powered industrial and consumer cleaning, protection and anti-fog solutions formulated in Detroit, Michigan. Nano Magic focuses on innovative and advanced product solutions harnessing the magic power of nanotechnology to create a safer, more socially conscious, and higher performing world. Visit www.nanomagic.com for more information.

 

Effective May 31, 2022, we sold a majority interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). ANI performs contract research services for the Company and for governmental and private customers and that work was previously reported as our Contract research segment. We retain a 30% interest in ANI that is now recorded as an equity investment.

 

RESULTS OF OPERATIONS

 

The following comparative analysis on results of operations was based primarily on the comparative condensed consolidated financial statements, footnotes and related information for the periods identified below and should be read in conjunction with the unaudited condensed consolidated financial statements and the notes to those statements that are included elsewhere in this report. The results discussed below are for the three and six months ended June 30, 2023 and 2022.

 

Comparison of Results of Continuing Operations for the Three and Six Months ended June 30, 2023 and 2022

 

Revenues:

 

For the three and six months ended June 30, 2023 and 2022, revenues from continuing operations were:

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Total revenue   $709,293   $493,782   $1,406,322   $1,012,925 

 

For the three months ended June 30, 2023, revenues from continuing operations increased by $215,511 or 44% as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023 revenues increased by $393,397 or 39%, as compared to the six months ended June 30, 2022. The increases were due to sales increases in multiple channels.

 

Cost of sales

 

Cost of sales includes inventory costs, materials and supplies costs, internal labor and related benefits, subcontractor costs, depreciation, and allocated overheads and shipping and handling costs incurred.

 

   Three Months ended June 30,   Six Months ended June 30, 
   2023   2022   2023   2022 
Cost of sales:  $507,155   $458,330   $1,129,434   $990,894 

 

For the three months ended June 30, 2023, cost of revenues increased by $48,825 or 11 % as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023, cost of revenues increased by $138,540 or 14% as compared to the six months ended June 30, 2022. Cost of sales increased as sales revenue increased, but did not increase proportionately reflecting cost cutting efforts over the last year.

 

4
 

 

Gross profit

 

For the three months ended June 30, 2023, gross profit was $202,138 as compared to $35,452 for the prior year, an increase of $166,686 or 470%. For the six months ended June 30, 2023, gross profit was $276,888 as compared to $22,031 for the prior year, an increase of $254,857 or 1,157%. For the three- and six-month periods the increases were due to higher sales volume as well as product mix generating improved margin year over year.

 

Operating expenses

 

For the three months ended June 30, 2023, operating expenses increased by $26,007 or 3% compared to the three months ended June 30, 2022. For the six-month period ended June 20, 2023, operating expenses decreased by $277,497 or 15% as compared to the six months ended June 30, 2022. For the three and six months ended June 30, 2023 and 2022, operating expenses consisted of the following:

 

   Three Months Ended June 30,   Six Months Ended June 30, 
   2023   2022   2023   2022 
Selling and marketing expenses  $54,018   $96,301   $113,442   $175,830 
Salaries, wages and related benefits   189,896    316,752    468,562    712,718 
Stock compensation expense   260,249    39,366    290,393    106,621 
Research and development   6,371    3,211    12,275    10,700 
Professional fees   112,762    188,794    302,221    442,773 
General and administrative expenses   258,508    211,463    447,514    463,261 
Total  $881,894   $855,887   $1,634,407   $1,911,903 

 

For the three months ended June 30, 2023, selling and marketing expenses decreased by $42,283 or 44% as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023, selling and marketing expenses decreased by $62,388 or 35% as compared to the six months ended June 30, 2022. The decreases were due to attendance at fewer trade shows in 2023 and the decision to bring certain consumer marketing efforts in-house.
   
For the three months ended June 30, 2023, salaries, wages and related benefits decreased by $126,766 or 40%, as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023, salaries, wages and related benefits decreased by $244,156 or 34%, as compared to the six-months ended June 30, 2022. These decreases were due to reductions in headcount.
   
For the three months ended June 30, 2023, stock compensation expense increased by $220,883 or 561%. For the six months ended June 30, 2023, stock compensation expense increased $183,772 or 172%. The increase was due in substantial part to the grant of options to employees in lieu of cash bonuses, payment of a portion of some salaries in options in lieu of cash, and other stock incentives to employees and consultants.

 

For the three months ended June 30, 2023, research and development costs increased by $3,160 or 98%, as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023, research and development costs increased by $1,575 or 15%, as compared to the six months ended June 30, 2022. The changes were due to product development and testing expenses.
   
For the three months ended June 30, 2023, professional fees decreased by $76,032 or 40%, as compared to the three months ended June 30, 2022. For the six months ended June 30, 2023, professional fees decreased by $140,552 or 32%, as compared to the six months ended June 30, 2022. The changes were due to a reduction in fees from professional services firms used by the Company.
   
For the three months ended June 30, 2023, general and administrative expenses increased by $47,045 or 22% as compared to the three months ended June 30, 2022 due to an increase in bad debt expenses for the quarter. For the six months ended June 30, 2023, general and administrative expenses decreased by $15,747 or 3% as compared to the six months ended June 30, 2022 due to efforts to control costs in light of reduced sales.

 

5
 

 

Other Operating Income

 

For the three and six months ended June 30, 2023, other operating income amounted to $11,420 as compared to $0 for the three and six months ended June 30, 2022. The difference is due to one-time income booked for the settlement of a claim with a supplier in April of 2023.

 

Loss from operations

 

As a result of the factors described above, for the three months ended June 30, 2023, loss from operations amounted to $668,336 as compared to a loss of $820,435 for the three months ended June 30, 2022, a reduction of $152,099 or 19%. For the six months ended June 30, 2023, loss from operations amounted to $1,346,099 as compared to a loss of $1,889,872 for the six months ended June 30, 2022, a reduction of $543,773 or 29%.

 

Income from investment in subsidiary

 

As a result of the sale of a 70% interest in ANI , we now report our 30% share of ANI’s income or loss as an investment in a subsidiary. For the three and six months ended June 30, 2023 there was income of $8,782 and $40,938, respectively. For the three and six-month periods ended June 30, 2022, we recorded a loss from that investment of $3,161.

 

Interest expense

 

For the three months ended June 30, 2023 interest expense was $7,575 as compared to $8,337 in the prior year, and for the six months ended June 30, 2023 interest expense was $21,943 up from $15,635 in the prior year. The decrease for the three-month period was due in substantial part to the payment of the Key Bank financing and reduced interest payable as financing leases mature. The increase in the six-month comparative period was due to accrued interest on convertible notes outstanding.

 

Other income

 

For the three months ended June 30, 2023, other income was $16,264 as compared to $3,886 for the three months ended June 30, 2022. For the six months ended June 30, 2023, other income was $23,202 as compared to $2,625 for the six months ended June 30, 2022. The increase was due to a non-recurring tax refund plus interest income on the note receivable from a subsidiary.

 

Loss from continuing operations

 

As a result of the foregoing, we reported a loss from continuing operations of $650,865 for the three-month period ended June 30, 2023 and a loss of $828,047 for the three-month period in the prior year, a reduction of $177,182 or 21%. For the six-month period ended June 30, 2023 our loss from continuing operations was $1,303,902 as compared to $1,906,043 for the six-month period ended June 30, 2022, a reduction of $602,141 or 32%.

 

Income (loss) from discontinued operations

 

Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of its officers and long-time employees in exchange for a promissory note in the face amount of $450,000. On a continuing basis, we no longer recognize income from this operation in the statement of operations. For the three and six months ended June 30, 2022, we recognized a loss of $13,045 and income of $1,300, respectively. For the three and six months ended June 30, 2022, we recognized a one-time gain on the sale of discontinued operations of $1,148,225.

 

Net loss (income)

 

For the three months ended June 30, 2023, net loss was $650,865 as compared to net income of $307,133 for the three months ended June 30, 2022. For the six months ended June 30, 2023, net loss amounted to $1,303,902 as compared to a loss of $756,518 for the six months ended June 30, 2022. The net income in the quarter ended June 30, 2022 was primarily attributed to the one-time gain of $1,148,225 recognized on the sale of ANI that also offset some of the losses for the six-month period in 2022.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Liquidity is the ability of an enterprise to generate adequate amounts of cash to meet its needs for cash requirements. We had working capital of $125,261 and $19,813 of unrestricted cash as of June 30, 2023 and working capital of $524,389 and $259,223 of unrestricted cash as of December 31, 2022.

 

6
 

 

The following table sets forth a summary of changes in our working capital from December 31, 2022 to June 30, 2023:

 

          

December 31, 2022 to

June 30, 2023

 
   June 30,
2023
   December 31, 2022  

Change in

Working

Capital

  

Percentage

Change

 
Working capital:                    
Total current assets  $1,491,328   $1,900,858   $(409,530)   (21.54)%
Total current liabilities   1,366,067    1,376,469    10,402    0.76%
Working capital:  $125,261   $524,389   $(399,128)   (76.11)%

 

The decrease in current assets was primarily due to a reduction in cash and in prepaid expenses. The increase in current liabilities was primarily due to an increase in accrued expenses, the current portion of notes payable and the current portion of operating lease liabilities, partially offset by a decrease in accounts payable.

 

Net cash used by operating activities was $(725,395) for the six months ended June 30, 2023 as compared to net cash used by operating activities of $(1,163,180) for the six months ended June 30, 2022, a net change of $437,785 or a reduction of 38%. Net cash used by operating activities for the six months ended June 30, 2023 primarily resulted from net loss from continuing operations of $1,303,902 adjusted for add-backs of $416,037 and changes in operating assets and liabilities of $162,470.

 

Net cash provided by continuing investing activities was $17,171 for the six months ended June 30, 2023, as compared to net cash used by continuing investing activities of $(4,910) for the same period in 2022. The change was due in substantial part to payment on the note from a subsidiary.

 

Net cash provided by continuing financing activities was $468,814 for the six months ended June 30, 2023 reflecting $445,000 in proceeds from sales of common stock, warrants and convertible notes, as compared to net cash provided by continuing financing activities of $1,298,146 for the same period in 2022. Net cash provided by discontinued financing activities was $0 and $20,000 for the six months ended June 30, 2023 and June 30, 2022, respectively.

 

Future Liquidity and Capital Needs.

 

Our principal future uses of cash are for working capital requirements, including working capital to support increased product sales, sales and marketing expenses and reduction of accrued liabilities. Application of funds among these uses will depend on numerous factors including our sales and other revenues and our ability to control costs.

 

Equipment Financing and Loans

 

See note 5 to our unaudited condensed consolidated financial statements regarding our equipment loan and financing leases.

 

Off-Balance Sheet Arrangements

 

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as shareholder’s equity or that are not reflected in our consolidated unaudited financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

ITEM 3. Quantitative and Qualitative disclosures about market risk

 

Not applicable to smaller reporting companies.

 

7
 

 

ITEM 4. Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as of the end of the period covered by this report (the “Evaluation Date”). Based upon this evaluation, our principal executive officer and principal financial officer concluded that we do not have sufficient resources in our accounting function to have segregation of duties so that the initiation of transactions, the custody of assets and the recording of transactions are performed by separate individuals. However, to the extent possible, these tasks are performed by separate individuals. Management evaluated our failure to have segregation of duties on our assessment of our disclosure controls and procedures and has concluded that the control deficiency that resulted represented a material weakness.

 

Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

Changes in Internal Control

 

There were no changes identified in connection with our internal control over financial reporting during the three months ended June 30, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

None

 

ITEM 1A. RISK FACTORS

 

Not required of smaller reporting companies.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan and an additional 30,000 in options to Tom J. Berman our President. The options were granted to individuals in lieu of cash for a portion of their salary for the period from December 31, 2022 through March 31, 2023. All options are at an exercise price of $0.65 per share for a four-year term and were fully vested on date of grant.

 

On April 14, 2023, the Company sold 196,851 shares of common stock to an accredited investor for proceeds of $246,064 and sold to that investor warrants to purchase up to 196,813 shares of common stock for proceeds of $3,936. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75.

 

On May 8, 2023, as part of a settlement agreement entered into on April 27, 2023, the Company sold to the counterparty 57,143 shares of common stock for proceeds of $100,000 at a price of $1.75 per share.

 

In March 2023, we issued 52,800 shares of common stock to our landlord in partial payment of our rent in Michigan.

 

On May 30, 2023 the Board granted 175,071 options under the 2021 Equity Plan to employees and consultants and an additional 399,228 options to officers and to a consultant who is also a director. All options are at an exercise price of $0.65 per share.

 

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services.

 

On June 16, 2023, the Company issued a note at face value of $50,000 and sold that investor, for a price of $0.02 per warrant, warrants to purchase up to 10,000 shares of common stock at an exercise price of $1.75. On July 24, 2023, the Company sold a convertible note at its face amount of $50,000. On that same day, the Company sold 133,333 shares of common stock for proceeds of $100,000.

 

In July and August 2023, the Company granted an aggregate of 192,302 shares of restricted stock to four individuals who will serve on the advisory committee.

 

Grants under the 2021 Equity Plan were exempt under Rule 701. The sales and issuances of stock and other securities were exempt from registration under Section 4(a)(2) of the Securities Act. Cash proceeds were used for general corporate purposes.

 

8
 

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

Exhibit
No.
  Description
31.1*   Rule 13a-14(a)/15d-14(a) Certificate of Principal Executive Officer
     
31.2*   Rule 13a-14(a)/15d-14(a) Certificate of Chief Financial Officer
     
32.1*   Section 1350 Certificate of Principal Executive Officer and Chief Financial Officer
     
101.INS   Inline XBRL Instance Document
     
101.SCH   Inline XBRL Taxonomy Extension Schema
     
101.CAL   Inline XBRL Taxonomy Extension Calculation
     
101.DEF   Inline XBRL Taxonomy Extension Definition
     
101.LAB   Inline XBRL Taxonomy Extension Labels
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
*   Filed herewith.

 

9
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

Nano Magic Inc.

(Registrant)

   
Date: August 14, 2023 /s/ Tom J. Berman
  Tom J. Berman,
  President and Chief Executive Officer
   
Date: August 14, 2023 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

10

 

Exhibit 31.1

 

Certificate of Principal Executive Officer

Pursuant to Rule 13a-14(a)/15d-14(a)

 

I, Tom J. Berman, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2023 of Nano Magic Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting) as defined in the Exchange Act Rules 13a - 15(f) and 15d - 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023 /s/ Tom J. Berman
 

Tom J. Berman

President and Chief Executive Officer

 

 

 

Exhibit 31.2

 

Certificate of Principal Financial Officer

Pursuant to Rule 13a-14(a)/15d-14(a)

 

I, Leandro Vera, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarterly period ended June 30, 2023 of Nano Magic Inc. (the “registrant”);

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present, in all material respects, the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting) as defined in the Exchange Act Rules 13a - 15(f) and 15d - 15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 14, 2023 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

 

 

Exhibit 32.1

 

Section 1350 Certification of Principal Executive Officer

 

In connection with the quarterly report of Nano Magic Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Tom J. Berman, President of the Company, and I, Leandro Vera, Chief Financial Officer, certify to the best of our knowledge:

 

1. The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: August 14, 2023 /s/ Tom J. Berman
  Tom J. Berman
  President and Chief Executive Officer
   
Date: August 14, 2023 /s/ Leandro Vera
  Leandro Vera
  Chief Financial Officer

 

 

 

v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 14, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 1-11602  
Entity Registrant Name NANO MAGIC INC.  
Entity Central Index Key 0000891417  
Entity Tax Identification Number 47-1598792  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 31601 Research Park Drive  
Entity Address, City or Town Madison Heights  
Entity Address, State or Province MI  
Entity Address, Postal Zip Code 48071  
City Area Code (844)  
Local Phone Number 273-6462  
Title of 12(b) Security Common Stock, $0.0001 par value  
Trading Symbol NMGX  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   11,429,666
v3.23.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
NET REVENUES $ 709,293 $ 493,782 $ 1,406,322 $ 1,012,925
COST OF SALES 507,155 458,330 1,129,434 990,894
GROSS PROFIT 202,138 35,452 276,888 22,031
OTHER OPERATING INCOME 11,420 11,420
OPERATING EXPENSES:        
Selling and marketing expenses 54,018 96,301 113,442 175,830
Salaries, wages and related benefits 189,986 316,752 468,562 712,718
Stock compensation expense 260,249 39,366 290,393 106,621
Research and development 6,371 3,211 12,275 10,700
Professional fees 112,762 188,794 302,221 442,773
General and administrative expenses 258,508 211,463 447,514 463,261
Total Operating Expense 881,894 855,887 1,634,407 1,911,903
LOSS FROM OPERATIONS (668,336) (820,435) (1,346,099) (1,889,872)
OTHER INCOME (EXPENSE)        
Income (loss) from investment in subsidiary 8,782 (3,161) 40,938 (3,161)
Interest expense (7,575) (8,337) (21,943) (15,635)
Other income 16,264 3,886 23,202 2,625
Total Other Income (Expense) 17,471 (7,612) 42,197 (16,171)
LOSS FROM CONTINUING OPERATIONS (650,865) (828,047) (1,303,902) (1,906,043)
INCOME (LOSS) FROM DISCONTINUED OPERATIONS        
Income (loss) from discontinued operations (13,045) 1,300
Gain on sale of discontinued operations 1,148,225 1,148,225
NET INCOME FROM DISCONTINUED OPERATIONS 1,135,180 1,149,525
NET (LOSS) INCOME $ (650,865) $ 307,133 $ (1,303,902) $ (756,518)
NET (LOSS) INCOME PER SHARE - BASIC:        
Continuing operations $ (0.06) $ (0.08) $ (0.12) $ (0.19)
Discontinued operations 0.11 0.11
NET (LOSS) INCOME PER SHARE - BASIC: (0.06) 0.03 (0.12) (0.08)
NET (LOSS) INCOME PER SHARE - DILUTED:        
Continuing operations (0.06) (0.08) (0.12) (0.19)
Discontinued operations 0.11 0.11
NET (LOSS) INCOME PER SHARE - DILUTED: $ (0.06) $ 0.03 $ (0.12) $ (0.08)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic 10,963,268 10,084,334 10,907,579 10,082,511
Diluted 10,963,268 10,084,334 10,907,579 10,082,511
v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash $ 19,813 $ 259,223
Accounts receivable, net 353,750 348,565
Inventory, net 1,049,562 1,120,073
Prepaid expenses 23,203 132,997
Current portion of note receivable 45,000 40,000
Total Current Assets 1,491,328 1,900,858
Operating lease right-of-use assets 943,100 1,037,749
Property, plant and equipment, net 472,373 525,809
Note receivable, non-current 326,175 375,983
Non-marketable equity investment in subsidiary 291,085 250,146
Total Assets 3,524,061 4,090,545
CURRENT LIABILITIES:    
Accrued expenses and other current liabilities 327,761 276,132
Current portion of notes payable 25,000 26,629
Current portion of finance leases 26,248 39,005
Advances from related parties 42,887 42,887
Current portion of operating lease liabilities 153,488 142,173
Total Current Liabilities 1,366,067 1,376,469
Notes payable and debt discount, net of current portion 394,667 350,000
Finance leases, net of current portion 12,396 24,194
Operating lease liabilities, net of current portion 630,646 722,420
Total Liabilities   2,403,776 2,473,083
Commitments and Contingencies (See Note 11)
STOCKHOLDERS’ EQUITY:    
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding
Common stock: $0.0001 par value, 30,000,000 shares authorized; 11,180,953 and 10,722,431 issued and outstanding at June 30, 2023 and December 31, 2022, respectively 1,117 1,072
Additional paid-in capital 14,569,823 13,763,143
Accumulated deficit (13,450,655) (12,146,753)
Total Stockholders’ Equity 1,120,285 1,617,462
Total Liabilities and Stockholders’ Equity 3,524,061 4,090,545
Nonrelated Party [Member]    
CURRENT LIABILITIES:    
Accounts payable - related parties 690,066 762,524
Related Party [Member]    
CURRENT LIABILITIES:    
Accounts payable - related parties $ 100,617 $ 87,119
v3.23.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Jun. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 100,000 100,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 11,180,953 10,722,431
Common stock, shares outstanding 11,180,953 10,722,431
v3.23.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Common Class A [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 970 $ 11,960,011 $ (10,045,164) $ 1,915,817
Balance, shares at Dec. 31, 2021 9,702,680      
Common stock issued for cash, net of issuance costs $ 66 1,152,020 1,152,086
Common stock issued for cash, net of issuance costs, shares 658,335      
Stock-based compensation 106,621 106,621
Warrants and options on private placement 32,913 32,913
Net income (loss) (756,518) (756,518)
Balance at Jun. 30, 2022 $ 1,036 13,251,565 (10,801,682) 2,450,919
Balance, shares at Jun. 30, 2022 10,361,015      
Balance at Mar. 31, 2022 $ 1,008 12,702,228 (11,108,815) 1,594,421
Balance, shares at Mar. 31, 2022 10,077,681      
Common stock issued for cash, net of issuance costs $ 28 495,806 495,834
Common stock issued for cash, net of issuance costs, shares 283,334      
Stock-based compensation 39,366 39,366
Warrants and options on private placement 14,165 14,165
Net income (loss) 307,133 307,133
Balance at Jun. 30, 2022 $ 1,036 13,251,565 (10,801,682) 2,450,919
Balance, shares at Jun. 30, 2022 10,361,015      
Balance at Dec. 31, 2022 $ 1,072 13,763,143 (12,146,753) 1,617,462
Balance, shares at Dec. 31, 2022 10,722,431      
Common stock issued for cash, net of issuance costs $ 32 439,539 439,571
Common stock issued for cash, net of issuance costs, shares 328,800      
Stock-based compensation 285,683 285,683
Stock issued for services $ 5 65,995 66,000
Stock issued for services, shares 52,800      
Warrants and options on private placement 10,761 10,761
Net income (loss) (1,303,902) (1,303,902)
Restricted stock issued for services 8 4,702 4,710
Restricted stock issued for services, shares 76,922      
Balance at Jun. 30, 2023 $ 1,117 14,569,823 (13,450,655) 1,120,285
Balance, shares at Jun. 30, 2023 11,180,953      
Balance at Mar. 31, 2023 $ 1,084 13,954,274 (12,799,790) 1,155,568
Balance, shares at Mar. 31, 2023 10,850,037      
Common stock issued for cash, net of issuance costs $ 25 346,039 346,064
Common stock issued for cash, net of issuance costs, shares 253,994      
Stock-based compensation 255,539 255,539
Stock issued for services $ 8 4,702 4,710
Stock issued for services, shares 76,922      
Warrants and options on private placement 9,269 9,269
Net income (loss) (650,865) (650,865)
Balance at Jun. 30, 2023 $ 1,117 $ 14,569,823 $ (13,450,655) $ 1,120,285
Balance, shares at Jun. 30, 2023 11,180,953      
v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss from continuing operations $ (1,303,902) $ (1,906,043)
Net income from discontinued operations 1,149,525
Adjustments to reconcile net loss to net cash provided by operating activities:    
Change in inventory obsolescence reserve (3,680) 2,331
Depreciation and amortization expense 56,265 56,159
Bad debt expense 47,997 30,629
Stock-based compensation and stock issued for services 356,393 106,621
Income from investment in subsidiary (40,938)
Change in operating assets and liabilities:    
Accounts receivable (53,181) 23,121
Inventory 74,190 52,166
Prepaid expenses and contract assets 109,794 30,636
Accounts payable (47,650) 249,340
Accounts payable - related party 13,498 (6,065)
Operating lease liabilities 14,190 29,575
Accrued expenses 51,629 79,607
Contract liabilities 159,688
Total adjustments 578,507 813,808
Net cash used by continuing operating activities (725,395) (1,092,235)
Net cash used by discontinued operating activities (70,945)
NET CASH USED BY OPERATING ACTIVITIES (725,395) (1,163,180)
CASH FLOWS FROM CONTINUING INVESTING ACTIVITIES    
Proceeds from note receivable 20,000
Purchases of property and equipment (2,829) (4,910)
NET CASH PROVIDED (USED) BY INVESTING ACTIVITIES 17,171 (4,910)
CASH FLOWS FROM CONTINUING FINANCING ACTIVITIES    
Proceeds from sale of common stock and warrants 445,000 1,184,999
Proceeds from issuance of convertible debt and warrants 50,000 200,000
Repayment of bank loans (1,630) (15,454)
Repayment of finance leases (24,556) (20,334)
Repayment of advances from related parties (51,065)
Net cash provided by continuing financing activities 468,814 1,298,146
Net cash provided by discontinued financing activities 20,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 468,814 1,318,146
NET (DECREASE) INCREASE IN CASH (239,410) 150,056
CASH in continuing operations, beginning of period 259,223 197,932
CASH in discontinued operations, beginning of period 44,542
CASH, end of period 19,813 392,530
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest $ 21,943 $ 15,635
v3.23.2
ORGANIZATION AND BASIS OF PRESENTATION
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND BASIS OF PRESENTATION

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

Organization

 

Nano Magic Inc. (“we”, “us”, “our”, “Nano Magic” or the “Company”), a Delaware corporation, develops and sells a portfolio of nano-layer coatings, nano-based cleaners, and nano-composite products based on its proprietary technology. On March 2, 2021 we changed our name to Nano Magic Holdings Inc. On December 31, 2022, our wholly-owned subsidiary Nano Magic LLC was merged into the parent company and we changed our name to Nano Magic Inc.

 

Effective May 31, 2022, we sold a 70% interest in our subsidiary, Applied Nanotech, Inc. (“ANI”). The contract research services performed by ANI for governmental and private customers was previously reported as our Contract research segment. As a result of this sale, the Company has deconsolidated ANI from its financial reporting, and we now report as only one segment. We retain a 30% interest in ANI that is now recorded as an equity investment.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) for interim financial information. Accordingly, they do not include all the information and disclosures required by US GAAP for annual financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of June 30, 2023 and for the three and six months ended June 30, 2023 and 2022. The results of operations for the three and six months ended June 30, 2023 are not necessarily indicative of the operating results for the full year ending December 31, 2023 or any other period. The balance sheet at December 31, 2022 has been derived from the audited financial statement at that date but does not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related disclosures of the Company as of December 31, 2022 and for the year then ended, which were filed with the Securities and Exchange Commission on Form 10-K on April 11, 2023.

 

Going Concern

 

These unaudited consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the unaudited consolidated financial statements, the Company had losses from continuing operations and net cash used by continuing operations of $1,303,902 and $725,395 for the six months ended June 30, 2023 and a loss from continuing operations of $1,906,043 and cash used by continuing operations $1,092,235 for the six months ended June 30, 2022. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these unaudited consolidated financial statements are issued. Management cannot provide assurance that the Company will ultimately achieve profitable operations, become cash flow positive or raise additional capital. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. They do not include any adjustments related to the recoverability and/or classification of the recorded asset amounts and/or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Reclassifications

 

Certain accounts and financial statement captions in the prior periods have been reclassified to conform to the current period. These reclassifications had no effect on the previously reported net loss.

 

v3.23.2
DISCONTINUED OPERATIONS
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS

NOTE 2 – DISCONTINUED OPERATIONS

 

Effective May 31, 2022, we sold a 70% interest in our subsidiary ANI to two of its officers and long-term employees in exchange for a promissory note in the face amount of $450,000. The note bears interest at 7% and has semi-annual payments of principal initially in the amount of $20,000, increasing to $25,000 in May 2024 and to $30,000 in May 2026, with a final balloon payment of $80,000 due on December 31, 2029. The note is secured by a stock pledge, described below. In conjunction with the sale, we recognized a one-time gain of $1,148,225.

 

 

In connection with the sale, the capital structure of Applied Nanotech was changed to give us, as the holder of Class B common stock of Applied Nanotech, a 30% economic interest, certain information rights, special consent rights, and tag-along rights, as well as the obligation to sell our stock under certain circumstances if other stockholders are selling. The Class A stock acquired by the buyers was pledged to secure the promissory note given in payment of the purchase price.

 

The following includes the detail of major classes of assets and liabilities of discontinued operations summarized on the accompanying unaudited consolidated financial statements:

 

The following is the detail of major line items that constitute income (loss) from discontinued operations:

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Net Revenues  $-   $91,329   $-   $258,444 
Cost of Sales   -    76,947    -    211,029 
Gross Profit   -    14,382    -    47,415 
                     
Salaries, wages and related benefits   -    17,684    -    23,573 
General and administrative expenses   -    9,514    -    21,961 
Professional fees   -    -    -    - 
Interest and other expense   -    229    -    581 
Net income (loss) on discontinued operations  $-   $(13,045)  $-   $1,300 

 

 

v3.23.2
INVENTORY
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
INVENTORY

NOTE 3 – INVENTORY

 

At June 30, 2023 and December 31, 2022, inventory consisted of the following:

 

    June 30, 2023     December 31, 2022  
Raw materials   $ 665,155     $ 695,774  
Work-in-progress     241,110       256,095  
Finished goods     324,495       353,082  
Inventory, gross     1,230,760       1,304,951  
Less: reserve for obsolescence     (181,198 )     (184,878 )
Inventory, net   $ 1,049,562     $ 1,120,073  

 

v3.23.2
INVESTMENT IN SUBSIDIARY
6 Months Ended
Jun. 30, 2023
Investments, All Other Investments [Abstract]  
INVESTMENT IN SUBSIDIARY

NOTE 4 – INVESTMENT IN SUBSIDIARY

 

The Company is accounting for its 30% ownership interest in ANI by the equity method of accounting under which the Company’s share of the net income (loss) of ANI is recognized as income (loss) in the Company’s statement of operations. Any dividends received from ANI as well as periodic losses for the Company’s 30% share will be treated as a reduction of the investment account. At June 30, 2023, the investment was $291,085, included in non-current assets. For the three- and six-month periods ended June 30, 2023, the Company recorded income from the investment in the subsidiary of $8,782 and $40,938 respectively. For the three and six-month periods ended June 30, 2022, the Company recorded a net loss from the investment in subsidiary of $3,161.

 

v3.23.2
NOTES PAYABLE AND FINANCE LEASES
6 Months Ended
Jun. 30, 2023
Notes Payable And Finance Leases  
NOTES PAYABLE AND FINANCE LEASES

NOTE 5 – NOTES PAYABLE AND FINANCE LEASES

 

Notes Payable

 

On January 7, 2022, the Company sold to one investor a $100,000 convertible note due March 31, 2025. On January 26, 2022, and January 31, 2022, the Company sold two $50,000 convertible notes to two different investors. The two $50,000 notes are due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On July 27, 2022, the Company sold two convertible notes, one for $50,000 and one for $25,000, both due on March 31, 2025. On August 22, 2022, the Company sold a $25,000 convertible promissory note due March 31, 2026. All three notes were issued at face value, and bear interest at 8% per annum, payable semi-annually in cash. The notes are convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

 

On October 26, 2022, the Company sold to an investor a $25,000 convertible promissory note due October 31, 2023. Issued at face value, the note bears interest at 8% per annum, payable semi-annually in cash. The note is convertible at any time at the option of the holder into shares of common stock at a conversion price of $1.75 per share.

 

On December 18, 2022, the Company issued a convertible promissory note for $50,000 that is secured by certain payroll tax credits the Company is entitled to receive under the Employee Retention Tax Credit program. The note was issued at face value and bears interest at 8% per annum, payable at maturity which is eighteen months from date of issue. The note can be converted to common stock at any time at the option of the holders at a conversion price of $1.75 per share at which point accrued interest will be paid in cash.

 

On June 14, 2023, the Company issued a convertible, secured note and warrants to purchase 10,000 shares of the Company’s common stock for $50,000 with the same terms as the one issued on December 18, 2022. The warrants were recorded as a debt discount on the date of issuances for a total value of $5,333.

 

At June 30, 2023 and at December 31, 2022, we had outstanding convertible notes aggregating $419,667 and $375,000 in principal amount, net of unamortized debt discount of $5,333 and $0, respectively. The convertible promissory notes have not been included in diluted earnings per share as they would be anti-dilutive.

 

On February 10, 2015, Nano Magic entered into a $373,000 promissory note (the “Equipment Note”) with KeyBank, N.A. (the “Bank”). The unpaid principal balance of this Equipment Note was payable in 60 equal monthly instalments payments of principal and interest through June 10, 2020. The Equipment Note was secured by certain equipment, as defined in the Equipment Note, and bore interest computed at a rate of interest of 4.35% per annum based on a year of 360 days. On June 18, 2019, Nano Magic entered into an Amendment to the Equipment Note with the Bank. By the amendment, the maturity date of the note was extended until April 10, 2022, the interest rate was raised to 6.29% per year, and the monthly payments were reduced to $4,053 per month, including interest. On May 2, 2022, we amended the Equipment Note with Key Bank to extend the due date on the note until December 10, 2022. The interest rate remained the same at 6.29% per year and the monthly payments remained at $4,053 per month. At June 30, 2023, the principal amount due under the Equipment Note had been paid in full. At December 31, 2022, $1,629 was outstanding under the Equipment Note.

 

Finance Leases

 

On August 11, 2020, the company entered into a finance lease for furniture. We financed $60,684 over a period of 36 months with monthly payments of $1,972 during that time. As of June 30, 2023, the balance on the lease was $1,955 all of which is current.

 

On September 24, 2020, the company entered into a finance lease with Raymond Leasing Corporation for a forklift. Nano Magic LLC financed $14,250. The lease term is 36 months with monthly payments of $425. As of June 30, 2023, the balance on the lease was $1,266, all of which is current.

 

In December 2020, the company entered into a finance lease for production equipment. We financed $85,000 over a period of 48 months with monthly payments of $2,135 during that time. As of June 30, 2023, the balance on the lease was $35,422; the current and non-current portions were $23,026 and $12,396, respectively.

 

v3.23.2
RELATED PARTY TRANSACTIONS
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 6 – RELATED PARTY TRANSACTIONS

 

At June 30, 2023 and at December 31, 2022, accounts payable – related parties totaled $100,617 and $87,119, respectively, and is presented separately in current liabilities. These balances consist of amounts owed to directors and officers as well as to the landlord controlled by two of the Company’s directors.

 

Other compensation paid to directors was:

 

   2023   2022   2023   2022 
   Three Months ended June 30,   Six Months ended June 30, 
   2023   2022   2023   2022 
Ronald J. Berman   $-    $30,000+  $-   $84,150+
Tom J. Berman   $

60,000

*  $60,300*  $

120,000

*  $115,600*
Scott E. Rickert   $ -    $ 15,000++  $ -    $30,000++

 

+ Legal and consulting fees.
* Indicates gross amount accrued as salary. In an effort to save cash, the company is satisfying the accrued salary through a combination of cash and stock in each period.
++ Repayment of advances previously made to the Company

 

 

At June 30, 2023 and at December 31, 2022, aggregate advances from Scott & Jeanne Rickert were $42,887. On both those dates, accrued payroll for the Rickerts was an aggregate of $16,000, which is included within accounts payable – related parties on the accompanying balance sheets.

 

We granted options to our President and CEO Tom Berman in lieu of salary: In April, an option to purchase up to 30,000 shares, fully vested for salary not paid from January to March, and, in May, a second option for up to 69,228 shares that vest at the rate of 7,692 shares monthly for salary not paid in April and subsequent months of 2023. Also in May, we granted our Chief Financial Officer an option for up to 100,000 shares in recognition of his services from 2019 through 2022. Both our CFO and our General Counsel were granted options in May for up to 60,000 shares, vesting 5,000 shares per month starting in January 2023 and each month thereafter. In May, 2023, we also granted director Ronald Berman an option to purchase up to 50,000 shares for services previously rendered and granted him an option for 45,000 shares that vest at the rate of 5,000 shares per month beginning in April and for each calendar month of 2023. All options have an exercise price of $0.65 per share and a four-year term.

 

One of the purchasers of the 70% interest in Applied Nanotech in May, 2022, was Richard Fink who was one of our named executive officers until that sale.

 

Mr. Ron Berman and Mr. Tom Berman are the managers of the limited liability company that is the manager of PEN Comeback, LLC, PEN Comeback 2, LLC, Magic Growth, LLP, Magic Growth 2 LLC and Magic Growth 3 LLC. These five limited liability companies purchased shares of common stock and derivative securities from us in 2018, 2019, 2020, 2021 and 2022. See the subsection on Sales of Stock under Issuances of Common Stock in Note 7.

 

In addition, Mr. Tom Berman and Mr. Ron Berman are two of three individuals who share voting power of the sole manager of the limited liability company that is our landlord in Michigan. Together, Tom and Ron Berman hold, in the aggregate, a 5% economic interest in the landlord entity. Another director, Miles Gatland, owns a 12.5% interest in the Michigan landlord and he is a co-guarantor on the debt of that limited liability company. The lease for the Michigan facility gives us the right, during the first three years of the lease, to buy up to a 49% interest in the landlord for a price equal to 49% of the contributions received from other members. See Note 7, Stockholder’s Equity regarding the issuance of stock in partial satisfaction of unpaid rent. At June 30, 2023 and at December 31, 2022, rents accrued and unpaid totaled $57,111 and $57,119, respectively.

 

v3.23.2
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Description of Preferred and Common Stock

 

Preferred Stock

 

The preferred stock may be issued in one or more series. The Company’s board of directors are authorized to issue the shares of preferred stock in such series and to fix from time to time before issuance thereof the number of shares to be included in any such series and the designation, powers, preferences and relative, participating, optional or other rights, and the qualifications, limitations or restrictions thereof, of such series.

 

Common Stock

 

The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders.

 

Issuances of Common Stock

 

Common Stock Issued for Services

 

In February 2023, we reached an agreement with the landlord of our Michigan facility to accept 52,800 shares of our common stock at a price of $1.25 per share as partial payment of rent for the six-month period from October 2022 through March 2023. Those shares were issued in March, 2023.

 

 

In May 2023, we reached a further agreement with the landlord that calls for us to pay cash each month to cover the cost of the mortgage and the lease for the lighting fixtures, but that will allow us to pay the balance of the rent by issuing shares of our stock valued at $0.75 per share. We have the option to continue to use stock to pay a portion of the rent through 2024.

 

On May 30, 2023, the Company issued 76,922 shares of restricted common stock to a consultant as compensation for services. The shares are subject to forfeiture until vested. So long as the consulting services agreement remains in effect 4,273 shares vested in May for prior service, and another 4,273 shares vest at the end of May and each calendar month thereafter, with 4,277 shares vesting in December 2023. During 2024, 3,205 shares will vest at the end of each month, with 3,206 shares vesting at the end of December 2024.

 

Sales of Common Stock and Derivative Equity Securities

 

During the quarter ended June 30, 2023, the Company sold 253,994 shares of common stock for proceeds of $346,064 and warrants to purchase up to 196,813 shares of common stock for proceeds of $4,136. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. During the six-months ended June 30, 2023 the Company sold 328,800 shares of common stock for proceeds of $439,571 and warrants to purchase up to 271,439 shares of common stock for proceeds of $5,428. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $1.75. Also during the three-months ended June 30, 2023, the Company sold 10,000 warrants in connection with the issuance of a convertible note payable of $50,000 as disclosed in Note 5. In accordance with ASC 470, 11% of the value of the total convertible note payable was allocated to the warrants.

 

During the quarter ended June 30, 2022, the Company sold 283,334 shares of common stock for proceeds of $495,834 and warrants to purchase up to 283,310 shares of common stock for proceeds of $14,165. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $2.25. During the six-months ended June 30, 2022, the Company sold 658,335 shares of common stock for proceeds of $1,152,086 and warrants to purchase up to 658,275 shares of common stock for proceeds of $32,913. The warrants are exercisable at any time during the four years after date of issue at a warrant exercise price of $2.25.

 

Stock Options

 

Stock options to purchase common stock outstanding at June 30, 2023 include those described below. No options were exercised during the period. No options have been included in diluted earnings per share as they would be anti-dilutive.

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2022   2,760,991   $0.77    4.09   $777,723 
Exercised   -    -    -    - 
Issued   636,909    0.65    3.90    222,918 
Expired & forfeited   (21,580)   0.88    -    (5,382)
Outstanding June 30, 2023   3,376,320   $0.71    3.65   $995,259 
                     
Exercisable June 30, 2023   1,686,793   $0.67    2.92   $552,087 

 

 

    June 30, 2023     December 31, 2022  
Stock options     3,376,320       2,760,991  
Stock warrants     7,722,078       7,440,639  
Total     11,098,398       10,201,630  

 

 

Warrants

 

As of June 30, 2023, there were outstanding and exercisable warrants to purchase 7,722,078 shares of common stock. On May 26, 2022, the Board acted to extend the term of warrants that were issued in 2018, 2019, or the first quarter of 2020, adding an additional two years to the term of each of the 4,052,003 warrants issued in that period. The outstanding warrants have a weighted average exercise price of $1.72 per share and a weighted average remaining contractual term of 23.9 months. As of June 30, 2023, there was no intrinsic value for the warrants. No warrants have been included in diluted earnings per share as they would be anti-dilutive.

 

2021 Equity Incentive Plan

 

On March 2, 2021, our Board adopted the 2021 Nano Magic 2021 Equity Incentive Plan (the “Plan”) to allow equity compensation for those who provide services to the Company and to encourage ownership in the Company by personnel whose service to the Company is important to its continued progress, to encourage recipients to act as owners and thereby in the stockholders’ interest and to enable recipients to share in the Company’s success. Initially, 85,000 shares were available for issuance under the Plan and that number of options were also granted to employees on March 2, 2021. On April 8, 2021 the number of shares under the Plan was increased by 2,500, and an additional 2,500 options were granted. On June 21, 2021 an additional 200,000 shares were made available for issuance under the Plan and options for 100,000 shares were granted, but subsequently forfeited. In February 2022, we granted 130,700 options with an exercise price of $0.80 and weighted average fair value on the grant date of $0.60.

 

On April 12, 2023, the Company granted 47,610 options under the 2021 Equity Plan. On May 30, 2023 the Board granted an additional 175,071 options under the 2021 Equity Plan to employees and a consultant. All options are at an exercise price of $0.65.

 

Other Options

 

On April 12, 2023, the Company issued an additional 30,000 options to Tom J. Berman, our President. On May 30, 2023, the Board granted 384,228 options to officers and to a consultant who is also a director.

 

v3.23.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may be, from time to time, subject to various administrative, regulatory, and other legal proceedings arising in the ordinary course of business. As of June 30, 2023 we were not a defendant in any proceedings. Our policy is to accrue costs for contingent liabilities, including legal proceedings or unasserted claims that may result in legal proceedings, when a liability is probable and the amount can be reasonably estimated. As of June 30, 2023, the Company has not accrued any amount for litigation contingencies.

 

v3.23.2
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

On June 16, 2023, the Company issued a note at face value of $50,000 and sold that investor, for a price of $0.02 per warrant, warrants to purchase up to 10,000 shares of common stock at an exercise price of $1.75. In July 24, 2023, the Company sold a convertible note at its face amount of $50,000. On that same day, the Company sold 133,333 shares of common stock for proceeds of $100,000.

 

On July 19, 2023, the Board authorized the creation of an Advisory Committee. In August the Company agreed to issue to each of three individuals who will serve on that committee a total of 38,460 shares of restricted stock for their services during 2023.

v3.23.2
DISCONTINUED OPERATIONS (Tables)
6 Months Ended
Jun. 30, 2023
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF INCOME (LOSS) FROM DISCONTINUED OPERATIONS

The following is the detail of major line items that constitute income (loss) from discontinued operations:

 

   2023   2022   2023   2022 
   For the Three Months Ended   For the Six Months Ended 
   June 30,   June 30, 
   2023   2022   2023   2022 
                 
Net Revenues  $-   $91,329   $-   $258,444 
Cost of Sales   -    76,947    -    211,029 
Gross Profit   -    14,382    -    47,415 
                     
Salaries, wages and related benefits   -    17,684    -    23,573 
General and administrative expenses   -    9,514    -    21,961 
Professional fees   -    -    -    - 
Interest and other expense   -    229    -    581 
Net income (loss) on discontinued operations  $-   $(13,045)  $-   $1,300 

 

v3.23.2
INVENTORY (Tables)
6 Months Ended
Jun. 30, 2023
Inventory Disclosure [Abstract]  
SCHEDULE OF INVENTORY

At June 30, 2023 and December 31, 2022, inventory consisted of the following:

 

    June 30, 2023     December 31, 2022  
Raw materials   $ 665,155     $ 695,774  
Work-in-progress     241,110       256,095  
Finished goods     324,495       353,082  
Inventory, gross     1,230,760       1,304,951  
Less: reserve for obsolescence     (181,198 )     (184,878 )
Inventory, net   $ 1,049,562     $ 1,120,073  
v3.23.2
RELATED PARTY TRANSACTIONS (Tables)
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTY TRANSACTIONS

 

   2023   2022   2023   2022 
   Three Months ended June 30,   Six Months ended June 30, 
   2023   2022   2023   2022 
Ronald J. Berman   $-    $30,000+  $-   $84,150+
Tom J. Berman   $

60,000

*  $60,300*  $

120,000

*  $115,600*
Scott E. Rickert   $ -    $ 15,000++  $ -    $30,000++

 

+ Legal and consulting fees.
* Indicates gross amount accrued as salary. In an effort to save cash, the company is satisfying the accrued salary through a combination of cash and stock in each period.
++ Repayment of advances previously made to the Company
v3.23.2
STOCKHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
SCHEDULE OF STOCK OPTION PLAN ACTIVITY

 

   Number of
Options
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term
(Years)
  

Aggregate

Intrinsic

Value

 
Outstanding December 31, 2022   2,760,991   $0.77    4.09   $777,723 
Exercised   -    -    -    - 
Issued   636,909    0.65    3.90    222,918 
Expired & forfeited   (21,580)   0.88    -    (5,382)
Outstanding June 30, 2023   3,376,320   $0.71    3.65   $995,259 
                     
Exercisable June 30, 2023   1,686,793   $0.67    2.92   $552,087 
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS SHARE

 

    June 30, 2023     December 31, 2022  
Stock options     3,376,320       2,760,991  
Stock warrants     7,722,078       7,440,639  
Total     11,098,398       10,201,630  
v3.23.2
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)
6 Months Ended
May 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Related Party Transaction [Line Items]      
Net cash used by continuing operations   $ 1,303,902 $ 1,906,043
Net cash used by continuing operations   $ 725,395 $ 1,092,235
Parent [Member]      
Related Party Transaction [Line Items]      
Ownership percentage 30.00%    
Applied Nanotech, Inc. [Member]      
Related Party Transaction [Line Items]      
Sale of interest in subsidiary 70.00% 30.00%  
v3.23.2
SCHEDULE OF INCOME (LOSS) FROM DISCONTINUED OPERATIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Discontinued Operations and Disposal Groups [Abstract]        
Net Revenues $ 91,329 $ 258,444
Cost of Sales 76,947 211,029
Gross Profit 14,382 47,415
Salaries, wages and related benefits 17,684 23,573
General and administrative expenses 9,514 21,961
Professional fees
Interest and other expense 229 581
Net income (loss) on discontinued operations $ (13,045) $ 1,300
v3.23.2
DISCONTINUED OPERATIONS (Details Narrative) - USD ($)
6 Months Ended
May 31, 2022
Jun. 30, 2023
Jun. 16, 2023
Related Party Transaction [Line Items]      
Debt instrument face amount     $ 50,000
Applied Nanotech, Inc. [Member]      
Related Party Transaction [Line Items]      
Sale of interest in subsidiary 70.00% 30.00%  
Debt instrument face amount $ 450,000    
Debt instrument bear interest 7.00%    
Debt instrument, periodic payment, principal $ 20,000    
Balloon payment 80,000    
Gain on sale of discontinued operations 1,148,225    
Applied Nanotech, Inc. [Member] | May 2024 [Member]      
Related Party Transaction [Line Items]      
Debt instrument, periodic payment, principal 25,000    
Applied Nanotech, Inc. [Member] | May 2026 [Member]      
Related Party Transaction [Line Items]      
Debt instrument, periodic payment, principal $ 30,000    
v3.23.2
SCHEDULE OF INVENTORY (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 665,155 $ 695,774
Work-in-progress 241,110 256,095
Finished goods 324,495 353,082
Inventory, gross 1,230,760 1,304,951
Less: reserve for obsolescence (181,198) (184,878)
Inventory, net $ 1,049,562 $ 1,120,073
v3.23.2
INVESTMENT IN SUBSIDIARY (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Related Party Transaction [Line Items]          
Investment amount   $ 291,085   $ 291,085  
Income (loss) from investment in subsidiary   $ 8,782 $ (3,161) $ 40,938 $ (3,161)
Applied Nanotech, Inc. [Member]          
Related Party Transaction [Line Items]          
Sale of interest in subsidiary 70.00%     30.00%  
v3.23.2
NOTES PAYABLE AND FINANCE LEASES (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Oct. 26, 2022
Aug. 22, 2022
Jul. 27, 2022
May 02, 2022
Jan. 31, 2022
Jan. 26, 2022
Jan. 07, 2022
Sep. 24, 2020
Aug. 11, 2020
Jun. 18, 2019
Feb. 10, 2015
Dec. 31, 2020
Jun. 30, 2023
Dec. 31, 2022
Jun. 16, 2023
Jun. 14, 2023
Dec. 18, 2022
Warrants to purchase up                         10,000        
Proceeds from issuance of debt                         $ 5,333 $ 0      
Debt instrument, face amount                             $ 50,000    
Finance lease, liability                         35,422        
Finance lease, liability, current                         26,248 39,005      
Finance lease, liability, noncurrent                         12,396 24,194      
Production Equipment [Member]                                  
Finance lease, liability                       $ 85,000          
Lessee, finance lease, term of contract                       48 months          
Finance lease, principal payments                       $ 2,135          
Finance lease, liability, current                         23,026        
Finance lease, liability, noncurrent                         12,396        
Raymond Leasing Corporation [Member]                                  
Finance lease, liability               $ 14,250                  
Lessee, finance lease, term of contract               36 months                  
Finance lease, principal payments               $ 425                  
Finance lease, liability, current                         1,266        
Michigan Facility [Member]                                  
Finance lease, liability                 $ 60,684                
Lessee, finance lease, term of contract                 36 months                
Finance lease, principal payments                 $ 1,972                
Finance lease, liability, current                         1,955        
Convertible Promissory Notes [Member]                                  
Convertible notes payable                         $ 419,667 375,000     $ 50,000
Debt instrument conversion price                                 $ 1.75
Debt instrument, interest rate, stated percentage                                 8.00%
Equipment Note [Member] | Nano Magic LLC [Member]                                  
Debt instrument, maturity date                     Jun. 10, 2020            
Debt instrument, interest rate, stated percentage       6.29%           6.29% 4.35%            
Debt instrument, face amount                     $ 373,000            
Debt instrument, periodic payment       $ 4,053           $ 4,053              
Debt default long term debt amount                           $ 1,629      
Convertible Debt [Member]                                  
Convertible notes payable $ 25,000 $ 25,000     $ 50,000 $ 50,000 $ 100,000                    
Debt instrument, maturity date Oct. 31, 2023 Mar. 31, 2026     Mar. 31, 2026 Mar. 31, 2026 Mar. 31, 2025                    
Annual payable interest percentage 8.00% 8.00%     8.00% 8.00% 8.00%                    
Debt instrument conversion price $ 1.75 $ 1.75     $ 1.75 $ 1.75 $ 1.75                    
Warrants to purchase up                               10,000  
Convertible debt                               $ 50,000  
Convertible Debt [Member] | Two Investors [Member]                                  
Convertible notes payable         $ 50,000 $ 50,000                      
Convertible Debt One [Member]                                  
Convertible notes payable     $ 50,000                            
Debt instrument, maturity date     Mar. 31, 2025                            
Annual payable interest percentage     8.00%                            
Debt instrument conversion price     $ 1.75                            
Convertible Debt Two [Member]                                  
Convertible notes payable     $ 25,000                            
Debt instrument, maturity date     Mar. 31, 2025                            
Annual payable interest percentage     8.00%                            
Debt instrument conversion price     $ 1.75                            
v3.23.2
SCHEDULE OF RELATED PARTY TRANSACTIONS (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Ronald J. Berman [Member]        
Related Party Transaction [Line Items]        
Other compensation $ 30,000 [1] $ 84,150
Tom J. Berman [Member]        
Related Party Transaction [Line Items]        
Other compensation [2] 60,000 60,300 120,000 115,600
Scotte E. Rickert [Member]        
Related Party Transaction [Line Items]        
Other compensation $ 15,000 [3] $ 30,000 [3]
[1] Legal and consulting fees.
[2] Indicates gross amount accrued as salary. In an effort to save cash, the company is satisfying the accrued salary through a combination of cash and stock in each period.
[3] Repayment of advances previously made to the Company
v3.23.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Apr. 30, 2023
Jan. 31, 2023
Jun. 30, 2023
May 31, 2023
Dec. 31, 2022
May 31, 2022
Related Party Transaction [Line Items]            
Exercise price     $ 0.71   $ 0.77  
Lease description     The lease for the Michigan facility gives us the right, during the first three years of the lease, to buy up to a 49% interest in the landlord for a price equal to 49% of the contributions received from other members.      
Accrued rent     $ 57,111   $ 57,119  
Applied Nanotech [Member]            
Related Party Transaction [Line Items]            
Minority interest ownership percentage           70.00%
Miles Gatland [Member]            
Related Party Transaction [Line Items]            
Economic interest percentage     12.50%      
Tom Berman [Member]            
Related Party Transaction [Line Items]            
Number of option granted     69,228      
Number of shares vested     7,692      
Exercise price     $ 0.65      
Tom Berman [Member] | Maximum [Member]            
Related Party Transaction [Line Items]            
Number of option granted     30,000      
Chief Financial Officer [Member] | Maximum [Member]            
Related Party Transaction [Line Items]            
Number of option granted       100,000    
Chief Financial Officer And General Counsel [Member]            
Related Party Transaction [Line Items]            
Number of shares vested   5,000        
Chief Financial Officer And General Counsel [Member] | Maximum [Member]            
Related Party Transaction [Line Items]            
Number of option granted     60,000      
Ronald Berman [Member] | Maximum [Member]            
Related Party Transaction [Line Items]            
Number of option granted       50,000    
Himan [Member]            
Related Party Transaction [Line Items]            
Number of shares vested 5,000          
Himan [Member] | Maximum [Member]            
Related Party Transaction [Line Items]            
Number of option granted       45,000    
Tom Berman and Ron Berman [Member]            
Related Party Transaction [Line Items]            
Economic interest percentage     5.00%      
Related Party [Member]            
Related Party Transaction [Line Items]            
Accounts payable- related parties     $ 100,617   87,119  
Scott & Jeanne Rickert [Member]            
Related Party Transaction [Line Items]            
Aggregate advance     42,887   42,887  
Jeanne Rickert [Member]            
Related Party Transaction [Line Items]            
Accrued payroll     $ 16,000   $ 16,000  
v3.23.2
SCHEDULE OF STOCK OPTION PLAN ACTIVITY (Details) - USD ($)
1 Months Ended 6 Months Ended
Feb. 28, 2022
Jun. 30, 2023
Equity [Abstract]    
Number of Options, Outstanding, Beginning balance   2,760,991
Weighted Average Exercise Price, Outstanding, Beginning balance   $ 0.77
Weighted Average Remaining Contractual Terms (Years), Outstanding   4 years 1 month 2 days
Aggregate Intrinsic Value, Beginning balance   $ 777,723
Number of Options, Exercised  
Weighted Average Exercise Price, Exercised  
Aggregate Intrinsic Value, Exercised  
Number of Options, Issued 130,700 636,909
Weighted Average Exercise Price, Issued $ 0.80 $ 0.65
Weighted Average Remaining Contractual Terms (Years), Outstanding   3 years 10 months 24 days
Aggregate Intrinsic Value, Issued   $ 222,918
Number of Options, Issued   (21,580)
Weighted Average Exercise Price, Expired & forfeited   $ 0.88
Aggregate Intrinsic Value, expired and forfeited   $ (5,382)
Number of Options, Outstanding, Ending balance   3,376,320
Weighted Average Exercise Price, Outstanding, Ending balance   $ 0.71
Weighted Average Remaining Contractual Terms (Years), Outstanding   3 years 7 months 24 days
Aggregate Intrinsic Value, Ending balance   $ 995,259
Number of Options, Exercisable, Ending balance   1,686,793
Weighted Average Exercise Price, Exercisable, Ending balance   $ 0.67
Weighted Average Remaining Contractual Term (Years), Exercisable   2 years 11 months 1 day
Aggregate Intrinsic Value, Exercisable   $ 552,087
v3.23.2
SCHEDULE OF ANTIDILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS SHARE (Details) - shares
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 11,098,398 10,201,630
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 3,376,320 2,760,991
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total 7,722,078 7,440,639
v3.23.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 30, 2023
May 30, 2023
Apr. 12, 2023
Jun. 21, 2021
Apr. 08, 2021
Feb. 28, 2023
Feb. 28, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 16, 2023
May 02, 2023
Mar. 02, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Common stock, voting rights                   The rights of each share of common are the same with respect to dividends, distributions and rights upon liquidation. Holders of common stock each have one vote per share in the election of directors and other matters submitted to a vote of the stockholders        
Number of shares issued for service           52,800                
Share issued price per share           $ 1.25           $ 0.02 $ 0.75  
Warrant exercise price per share                       $ 1.75    
Warrants to purchase up               10,000   10,000        
Proceeds from convertible debt               $ 50,000   $ 50,000 $ 200,000      
Weighted average remaining contractual term                   3 years 7 months 24 days        
Number of stock options granted             130,700     636,909        
Excercise price             $ 0.80     $ 0.65        
Weighted average grant date fair value, per share             $ 0.60              
Tom J. Berman [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Deferred compensation arrangement with individual compensation     $ 30,000                      
Officers [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Deferred compensation arrangement with individual compensation $ 384,228                          
2021 Equity Incentive Plan [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Number of shares available for issuance         2,500                 85,000
Number of stock options granted   175,071 47,610   2,500                  
Number of shares available for future issuance       200,000                    
Number of share options, granted and forfeited       100,000                    
Common Stock and Derivative Equity Securities [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Sale of Stock, Number of Shares Issued in Transaction               253,994 283,334 328,800 658,335      
Sale of Stock, Consideration Received on Transaction               $ 346,064   $ 439,571 $ 1,152,086      
[custom:WarrantsToPurchaseUpShares]               196,813 283,310 271,439 658,275      
Proceeds from Issuance of Warrants               $ 4,136 $ 14,165 $ 5,428        
Warrant exercise price per share               $ 1.75 $ 2.25 $ 1.75 $ 2.25      
Warrant [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Warrant exercise price per share               $ 1.72   $ 1.72        
Class of warrant or right, outstanding               7,722,078   7,722,078        
Number of shares issued                   4,052,003        
Weighted average remaining contractual term                   23 months 27 days        
Restricted Stock [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Number of shares issued for service   76,922                        
Restricted Stock [Member] | Vested In May [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Vested shares   4,273                        
Restricted Stock [Member] | Vest at End of May [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Vested shares   4,273                        
Restricted Stock [Member] | Vesting in December 2023 [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Vested shares   4,277                        
Restricted Stock [Member] | Vest at End of Each Month in December 2024 [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Vested shares   3,205                        
Restricted Stock [Member] | Vesting at End of December 2024 [Member]                            
Accumulated Other Comprehensive Income (Loss) [Line Items]                            
Vested shares   3,206                        
v3.23.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Jul. 24, 2023
Aug. 31, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 16, 2023
May 02, 2023
Feb. 28, 2023
Subsequent Event [Line Items]              
Debt instrument face amount         $ 50,000    
Shares issued price per share         $ 0.02 $ 0.75 $ 1.25
Purchase of warrant shares         10,000    
Warrant exercise price per share         $ 1.75    
Proceeds from issuance of common stock     $ 445,000 $ 1,184,999      
Subsequent Event [Member]              
Subsequent Event [Line Items]              
Debt instrument face amount $ 50,000            
Number of shares issued 133,333            
Proceeds from issuance of common stock $ 100,000            
Number of restricted stock shares   38,460          

Nano Magic (QB) (USOTC:NMGX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Nano Magic (QB) Charts.
Nano Magic (QB) (USOTC:NMGX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Nano Magic (QB) Charts.